Latest News and Press Releases
Want to stay updated on the latest news?
-
Melbourne, VIC, Australia; New Haven, CT, USA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Cogstate, a leading neuroscience technology company, today announced the appointment of Kaycee Sink, MD, MAS, as...
-
Melbourne, VIC, Australia; New Haven, CT, USA, June 14, 2022 (GLOBE NEWSWIRE) -- Cogstate (ASX.CGS) a leading neuroscience technology company, today announced the formation of a Scientific Advisory...
-
Melbourne, VIC, Australia; New Haven, CT, USA, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Cogstate (ASX.CGS), via its global commercial partner Eisai Co., Ltd, is pleased to announce that Cogstate technology...
-
Melbourne, VIC, Australia; New Haven, CT, USA, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced its digital cognitive assessments were part of the...
-
Melbourne, VIC, Australia; New Haven, CT, USA, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today that four members of its executive...
-
Melbourne, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today the appointment of Chris Edgar, PhD as Chief Science Officer and Prof. Paul...
-
Melbourne, VIC, Australia; New Haven, CT, USA, April 29, 2020 (GLOBE NEWSWIRE) -- Cogstate Ltd (ASX:CGS) today announced an award from the Alzheimer's Drug Discovery Foundation’s (ADDF) Diagnostics...
-
New Haven, CT, Nov. 19, 2019 (GLOBE NEWSWIRE) -- The neuroscience technology company, Cogstate Ltd (ASX.CGS), announced today that Ken Billard has joined the company in the role of Chief Commercial...
-
New Haven, CT, April 05, 2018 (GLOBE NEWSWIRE) -- The cognitive science company, Cogstate Ltd (ASX.CGS) today announced the establishment of a Rare Disease and Pediatric Center of Excellence to lead...